安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Monitoring for Colorectal Cancer Recurrences
Whether there are signs that the cancer has spread, returned, or progressed Surveillance strategies aimed at early detection increase the chance that cancer can be treated and cured New tools are available to detect traces of cancer in the blood The odds for cancer recurrence are higher if the initial tumor was diagnosed at an advanced stage
- Treatment of Stage IV- Metastatic or Recurrent Colon Cancer
Colon cancer is classified as stage IV or metastatic when the cancer has spread to distant locations in the body and cannot be primarily treated with surgery; this may include the liver, lungs, bones, distant lymph nodes or other sites Patients diagnosed with stage IV colon cancer have an increasing number of treatment options as a result of genomic testing and the development of precision
- ctDNA-based molecular residual disease and survival in . . .
The key inclusion criteria for this analysis included confirmed pathological stage I–V colon cancer or stage IV recurrent rectal cancer, R0 resection margins, availability of at least one ctDNA
- Differences in survival and recurrence of colorectal cancer . . .
Differences in survival and recurrence of colorectal cancer by stage across population-based European registries Anne-Marie Bouvier, Digestive Cancer Registry of Burgundy, University of Burgundy, BP 87900, 21079 Dijon Cedex, France
- Colon Cancer Survival Calculator | UT MD Anderson
The tumor stage according to American Joint Committee on Cancer staging system (v6)
- Incidence of Recurrence and Time to Recurrence in Stage I to . . .
This cohort study investigates stage-specific rates and timing of colorectal cancer recurrence using data from Danish national health registries from 2004 to 2019
- Recurrent Colon Cancer: Symptoms, Diagnosis, Treatment - WebMD
Learn about the symptoms, diagnosis, and treatment of recurrent colorectal cancer
- Colon Cancer - Guidelines Detail - NCCN
Final Weeks to Participate in the NCCN Guidelines User Survey! NCCN is reaching out to clinical oncology professionals to determine how to continually improve the NCCN Guidelines ® and other valuable NCCN Content Complete our 12-15 minute survey by June 30, 2026, and be entered for a chance to win a one-year subscription to an NCCN derivative product of choice US clinical oncology
|
|
|